129 related articles for article (PubMed ID: 1125725)
21. Urinary hydroxyproline and prognosis in human breast cancer.
Grant CS; Hoare SA; Millis RR; Hayward JL; Wang DY
Br J Surg; 1984 Feb; 71(2):105-8. PubMed ID: 6692099
[TBL] [Abstract][Full Text] [Related]
22. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Rinsho K; Aoyagi K
Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
[TBL] [Abstract][Full Text] [Related]
23. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
Lee CA; Lloyd HM
Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
[No Abstract] [Full Text] [Related]
24. Three-centre study on urinary hydroxyproline excretion in cancer of the breast.
Cuschieri A; Jarvie R; Taylor WH; Cant E; Furnival CM; Blumgart LH
Br J Cancer; 1978 Jun; 37(6):1002-5. PubMed ID: 678421
[TBL] [Abstract][Full Text] [Related]
25. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
[No Abstract] [Full Text] [Related]
26. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
[TBL] [Abstract][Full Text] [Related]
27. Influence of estradiol and estriol on urinary excretion of hydroxyproline in man.
Katz FH; Kappas A
J Lab Clin Med; 1968 Jan; 71(1):65-74. PubMed ID: 5635010
[No Abstract] [Full Text] [Related]
28. Hydroxyproline excretion in malignant neoplastic disease.
Hosley HF; Taft EG; Olson KB; Gates S; Beebe RT
Arch Intern Med; 1966 Dec; 118(6):565-71. PubMed ID: 5925444
[No Abstract] [Full Text] [Related]
29. The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer.
Niell HB; Neely CL; Palmieri GM; McDonald MW
Cancer; 1983 Oct; 52(8):1442-7. PubMed ID: 6616407
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
31. [Urinary hydroxyproline and cancer of the breast].
Bellido V; Carda P; Mascías E
Rev Esp Oncol; 1983; 30(1):7-16. PubMed ID: 6679910
[No Abstract] [Full Text] [Related]
32. Proceedings: Urinary hydorxyproline excretion in the monitoring of carcinoma of the breast.
Lester E
Br J Radiol; 1976 Mar; 49(579):290. PubMed ID: 1276611
[No Abstract] [Full Text] [Related]
33. Hydroxyproline and zinc excretion in patients with neoplastic breast disease.
Percudani M; Dell'Anna B; De Lorenzis GF; Ferraccioli GF; Vaona GL
Int Surg; 1981; 66(3):233-6. PubMed ID: 7319736
[TBL] [Abstract][Full Text] [Related]
34. Total urinary and free serum hydroxyproline in metastatic bone disease.
Gasser AB; Depierre D; Courvoisier B
Br J Cancer; 1979 Mar; 39(3):280-3. PubMed ID: 465297
[TBL] [Abstract][Full Text] [Related]
35. [On the excretion of bound hydroxyproline as an expression of changes in the organic cartilage and bone matrix].
Mühlbach R; Hirthe D; Lindenhayn K
Z Arztl Fortbild (Jena); 1966 May; 60(10):597-602. PubMed ID: 5997685
[No Abstract] [Full Text] [Related]
36. Urinary hydroxyproline excretion in myelofibrosis.
Wang JC; Aung MK; Tobin MS
Blood; 1980 Mar; 55(3):383-5. PubMed ID: 7357076
[TBL] [Abstract][Full Text] [Related]
37. Hydroxyproline as a marker for following patients with metastatic prostate cancer.
O'Brien WM; Lynch JH
J Urol; 1988 Jan; 139(1):66-8. PubMed ID: 3121868
[TBL] [Abstract][Full Text] [Related]
38. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
39. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
Radom S; Zulawski M; Golebiowska D
Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
[No Abstract] [Full Text] [Related]
40. [Hydroxyprolinuria and bone metastases of breast cancer].
Cruciani G; Bardella D; Fiorentini GM; Marangolo M; Tavolazzi L
Tumori; 1980 Apr; 66(2):205-13. PubMed ID: 7445102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
